• Thu. Sep 21st, 2023

News Eyeo

All Important News

rewrite this title What can urinary exosomes reveal about human health?


Sep 14, 2023

Exosomes, small extracellular vesicles released by human cells, have become a focus of biomedical research. These vesicles play various roles in the body, including metabolic activities, waste disposal, protein and nucleic acid exchange, coagulation, and immunological functions. Exosomes are involved in cellular communication and can carry functional cellular nucleic acids to target cells.

Urinary exosomes have been found to play a crucial role in the pathophysiology of human diseases and can be used as therapeutic targets. Researchers are particularly interested in the relationship between urinary exosomes and kidney function and injury. These exosomes can carry cargo throughout kidney cells, modify the proteome and function of recipient cells, and serve as intercellular signaling in the nephron. Urinary exosomes are easily obtained through non-invasive methods, making them cost-effective and valuable for disease research.

In the context of disease research, urinary exosomes have shown promise in the study of prostate cancer. Exosomes derived from prostate cancer cells have been found to influence stromal cells, promoting tumor development and metastasis. These exosomes can also increase chemosensitivity and serve as potential transporters for prostate cancer therapeutics. Additionally, the analysis of exosomes from body fluids, such as urine, can be used for the diagnosis of prostate cancer.

Urinary exosomes also hold potential for the study of other diseases, such as lupus nephritis. Certain exosomal microRNAs found in urine have shown promise in predicting disease progression in lupus nephritis patients. Furthermore, urinary exosomes can provide markers for kidney damage and dysfunction, allowing for non-invasive monitoring of disease progression and treatment.

However, there are limitations and challenges in utilizing urinary exosomes as disease markers. Factors such as sample collection, transportation, storage, and dilution can influence the results. Normalization strategies need to be developed to account for these factors. Additionally, the use of urine exosome-based indicators in clinical practice is currently limited due to performance differences, limited reliability, and high costs. Future research should focus on developing high-throughput technologies that can address these challenges and meet the demands of clinical diagnostic processes.

In conclusion, exosomes, particularly urinary exosomes, have emerged as valuable tools for disease research. They offer insights into disease pathogenesis, serve as potential therapeutic targets, and provide non-invasive diagnostic and prognostic markers. With further research and technological advancements, urinary exosomes hold promise for improving disease understanding, diagnosis, and treatment.

By Editor

Leave a Reply